News & Updates

Treatment with semaglutide and dulaglutide results in a significantly lower risk of adverse cognitive decline in patients with heart failure (HF), as shown by the results of a retrospective cohort study using real-world data.

Individuals with psoriasis may benefit from an increased level of serum 25-hydroxivitamin D (25[OH]D), which has shown an association with a reduced risk of overall mortality and cardiovascular disease (CVD) in a recent study.

Although guidelines recommend 12 months of dual antiplatelet therapy (DAPT) following a heart attack, results from the DUAL-ACS* trial appear to show otherwise.